glp 1 agonists mechanism of action Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review Mechanism of action for GLP-1R

In addition, the GLP-1 drug semaglutide (branded as Ozempic, Wegovy, and Rybelsus) was selected for Medicare drug price negotiation in 2025, with a negotiated price set to take effect in 2027

These are staggering numbers that suggest metabolic health and mental health are far more connected than we ever taught in medical school

However, realizing broader societal impact requires addressing fundamental cost, access, and long-term sustainability challenges

Given the rapid evolution of this field, future breakthroughs, including new drug approvals and expanded indications, necessitate systematic updates of the literature

doi: 10.1016/j.brainres.2012.07.029 137 McKieS.Del-BenC.ElliottR.WilliamsS.Del VaiN.AndersonI.et al

Data and code availability All data sourced from the FinnGen consortium (R9) ( Psychiatric Genomics Consortium (PGC, and UK Biobank ( All codes are available from the corresponding author through reasonable request